Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery

Titre officiel

Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery

Sommaire:

Cette étude évaluera si la mise en œuvre d’une combinaison de protocoles de récupération améliorée après une intervention chirurgicale (protocoles ERAS : Enhanced Recovery After Surgery) et de suivi postopératoire par l’intermédiaire d’une application pour téléphone intelligent permettrait : 1) l’amélioration de la satisfaction des patients; 2) la surveillance virtuelle des patients sans augmentation des visites postopératoires à l’urgence, du nombre et de la gravité des complications postopératoires et des réadmissions; 3) une diminution des coûts pour le système de santé et 4) une plus grande commodité et des coûts moindres pour les patients. L’étude sera menée auprès de femmes ayant subi une mastectomie, une reconstruction mammaire et des interventions gynécologiques en oncologie. La moitié des participantes fera l’objet d’une surveillance par un médecin au moyen d’une application pour téléphone intelligent. L’autre moitié recevra les soins habituels.

Description de l'essai

Primary Outcome:

  • Patient Satisfaction Questionnaire (PSQ-III) - Select Subscales
  • Quality of Recovery 15
Secondary Outcome:
  • Patient-borne Financial Costs of Followup Appointments
  • Total Number of Contacts with Medical System Postoperatively
  • Postoperative Complications
  • Adverse events NCI Version 3 / EORTC
  • Healthcare Professionals' Contact with Study Patients
  • Healthcare Professional Response to Virtual versus Traditional FollowUp Care

ERAS® (Enhanced Recovery After Surgery) protocols are evidence-based best practices bundled together to revolutionize pre-, intra-, and postoperative care resulting in better patient outcomes, increased patient postoperative satisfaction, and decreased healthcare costs. ERAS® protocols in breast reconstruction and gynecologic oncology have been developed by surgeons from the Tom Baker Cancer Centre and have the sanction of the international ERAS® Society for implementation globally.

As of 2015, the majority of Canadians owned a cell phone. Technological advances in these forms of communications have been shown to positively impact patient experience and reduce healthcare system burdens. Telemedicine delivered healthcare via smartphone apps now include platforms for encouraging healthy behaviours, monitoring chronic healthcare conditions, organizing personal healthcare records, and monitoring postsurgical wounds.

The proposed study would marry these two advances, ERAS® protocols and smartphone technology, to consider how the combination of these two approaches to postsurgical care might enhance patient satisfaction and convenience and minimize financial burden while providing high quality care and monitoring. Additionally, the combination of these approaches has the potential to benefit the healthcare system in a number of ways. By lessening surgery-related length of stay and reducing the number of postsurgical visits, an opportunity for cost-savings is evident. In addition, in a system that is troubled by long wait-times for some procedures, reducing lengths of stay and surgeons' postoperative clinical burden means more patients can be seen and treated in a timely fashion. This is a win-win for the healthcare system and patients. It provides structure for more efficiently caring for post-operative patients in a patient first manner that supports physicians, transforms care, and engages in responsible stewardship of healthcare resources according to the Foundational Strategies developed by Alberta Health Services.

The current study would assess the patient, physician, and healthcare system impact of combining ERAS® protocol-guided oncological surgery with postsurgical patient monitoring via a smartphone app that would lessen patients' postoperative burden when postoperative recovery is uneventful and would alert physicians earlier when things are not going well.

Voir cet essai sur ClinicalTrials.gov

Intéressé(e) par cet essai?

Imprimez cette page et apportez-la chez votre médecin pour discuter de votre admissibilité à cet essai et des options de traitement. Seul votre médecin peut vous recommander pour un essai clinique.

Ressources

Société canadienne du cancer

Ces ressources sont fournies en partenariat avec Société canadienne du cancer